Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

The method effectively detects MeT and TP in dried blood spots after cream application.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A 90-year-old man was diagnosed with heart failure due to wild-type transthyretin cardiac amyloidosis.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

The document's conclusion cannot be provided because the content is not available to parse.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

wAMD patients have higher oxidative stress, suggesting antioxidant treatment may help.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Temporal triangular alopecia is a non-scarring hair loss seen in some Asian children.

The treatment was not recommended due to limited effectiveness and significant side effects.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

The drug combination was safe and showed promise in treating advanced tumors.

Two sisters had a rare hair condition without other usual symptoms.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Specific mutations in a receptor cause facial abnormalities and hair loss.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

The sensor accurately measures thallium ions in solutions with high selectivity.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

The new hair treatment significantly reduces hair shedding safely.

Traditional Persian medicine helped a woman with resistant hyperthyroidism improve and stabilize her condition.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

The new hair product quickly reduces hair shedding in women.